Press Releases

Aptar Pharma, a leading drug delivery systems provider, is pleased to be exhibiting once again at CPhI China 2018, taking place from June 20-22 at the Shanghai New International Exhibition Center, Shanghai, China. At Booth No....

Lonza announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio. These hepatic non-parenchymal cells provide scientists with the building blocks to create more physiologically relevant in vitro...

Cleveland Clinic and Brooks Automation. Inc. willlaunch a 21,000-square-foot biorepository in Cleveland’s Fairfax neighborhood to enhance researchers’ study of human tissue samples and advance personalized medicine for an array of conditions – including cancer, heart disease, and epilepsy. ...

UCB announced that the U.S. FDA has approved a supplemental new drug application (sNDA) for the company’s newest anti-epileptic drug BRIVIACT CV oral formulations indicated as monotherapy and adjunctive therapy in the treatment of partial onset (focal) seizures in...

Novartis announced that the US FDA has approved Gilenya® (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis (RMS), making it the first disease-modifying therapy indicated...

Powder containment and aseptic transfer valve specialist, ChargePoint Technology, has launched a unique Smart monitoring hub to support efficiency and safety within chemical and pharmaceutical manufacturing processes. The company will be exhibiting its new VERIFI solution...

CRF Health, the leading provider of patient-centered eSource for the life sciences industry, announced that its electronic Clinical Outcome Assessment (eCOA) solutions have been selected for a significant insomnia trial by a European pharmaceutical company specializing in the discovery...